Both α and β isoforms of mammalian DNA topoisomerase II associate with chromosomes in mitosis

Cell Growth and Differentiation

Volumn 13, Issue 7, 2002, Pages 325-333

  Null, Allison P ^a   Hudson, Joanna ^a   Gorbsky, Gary J ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); ISOENZYME; ANTIBODY; DIAGNOSTIC AGENT; DNA; DNA BINDING PROTEIN; DNA TOPOISOMERASE II ALPHA; DNA TOPOISOMERASE II BETA; ISOPROTEIN; TUMOR ANTIGEN;

ARTICLE; CELLULAR DISTRIBUTION; CENTROMERE; CHROMATIN STRUCTURE; CHROMOSOMAL LOCALIZATION; CONTROLLED STUDY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; MITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANTIBODY SPECIFICITY; CELL NUCLEUS; CHROMOSOME; CYTOLOGY; DIPODOMYS; ENZYMOLOGY; EUKARYOTIC CELL; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HELA CELL; IMMUNOLOGY; METABOLISM;

ANIMAL; ANTIBODIES; ANTIBODY SPECIFICITY; CELL NUCLEUS; CHROMOSOMES; DIPODOMYS; DNA; DNA TOPOISOMERASES, TYPE II; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; EUKARYOTIC CELLS; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HUMAN; MITOSIS; PROTEIN ISOFORMS; SUPPORT, NON-U.S. GOV'T; ANIMALS; ANTIGENS, NEOPLASM; DNA-BINDING PROTEINS; HUMANS;

EID: 0035991818     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. The roles of DNA topoisomerase II during the cell cycle
2. Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme
3. Functional and regulatory characteristics of eukaryotic type II DNA topoisomerase
4. DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage
5. DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe
6. Chromosome assembly in vitro: Topoisomerase II is required for condensation
7. Role of DNA topoisomerase II in chromosome dynamics in mammalian cells
8. Cell cycle progression and chromosome segregation in mammalian cells cultured in the presence of the topoisomerase II inhibitors ICRF-187 ((+)-1,2-bis(3, 5-dioxopiperazinyl-1-yl)propane; ADR-529) and ICRF-159 (razoxane)
9. 1 phase in mammalian cells
10. Topoisomerase IIα is associated with the mammalian centromere in a cell cycle- and species-specific manner and is required for proper centromere/kinetochore structure
11. Topoisomerase II inhibitors affect entry into mitosis and chromosome condensation in BHK cells
12. In situ localization of DNA topoisomerase II, a major polypeptide component of the Drosophila nuclear matrix fraction
13. Nuclear matrix targets for anticancer agents
14. Discrete localization of different DNA topoisomerases in HeLa and K562 cell nuclei and subnuclear fractions
15. Topoisomerase II is a structural component of mitotic chromosome scaffolds
16. Metaphase chromosome structure involvement of topoisomerase II
17. Catalytic inhibitors of DNA topoisomerase II
18. Topoisomerase II as a target for anticancer drugs: When enzymes stop being nice
19. ATP-bound topoisomerase II as a target for antitumor drugs
20. Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes
21. Differential immunohistochemical staining for DNA topoisomerase II α and β in human tissues and for DNA topoisomerase II β in non-Hodgkin's lymphomas
22. Physiological regulation of eukaryotic topoisomerase II
23. Growth state- and cell cycle-dependent fluctuation in the expression of two forms of DNA topoisomerase II and possible specific modification of the higher molecular weight form in the M phase
24. Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities
25. Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells
26. Cloning and characterization of full-length cDNAs coding for the DNA topoisomerase II β from Chinese hamster lung cells sensitive and resistant 9-OH-ellipticine
27. Alterations in the topoisomerase II α gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II β enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line
28. DNA topoisomerase IIβ and neural development
29. Two differentially spliced forms of topoisomerase IIα and β mRNAs are conserved between birds and humans
30. Localization of DNA topoisomerase II in Chinese hamster fibroblasts by confocal and electron microscopy
31. Organization of DNA topoisomerase II isotypes during the cell cycle of human lymphocytes and HeLa cells
32. Localization of topoisomerase II in mitotic chromosomes
33. DNA topoisomerase IIα is the major chromosome protein recognized by the mitotic phosphoprotein antibody MPM-2
34. The distribution of topoisomerase II on mammalian chromosomes
35. The 180-kDa isoform of topoisomerase II is localized in the nucleolus and belongs to the structural elements of the nucleolar remnant
36. Monoclonal antibodies to human DNA topoisomerase I and the two isoforms of DNA topoisomerase II: 170- and 180-kDa isozymes
37. Redistribution and differential extraction of soluble proteins in permeabilized cultured cells
38. Rapid exchange of mammalian topoisomerase IIα at kinetochores and chromosome arms in mitosis
39. Essential mitotic functions of DNA topoisomerase IIα are not adopted by topoisomerase IIβ in human H69 cells
40. Analysis of M phase-specific phosphorylation of DNA topoisomerase II
41. Cell-cycle-dependent phosphorylation and activity of Chinese-hamster ovary topoisomerase II
42. Casein kinase II catalyzes a mitotic phosphorylation on threonine 1342 of human topoisomerase IIα, which is recognized by the 3F3/2 phosphoepitope antibody
43. In vivo phosphorylation of the 170-kDa form of eukaryotic DNA topoisomerase II. Cell cycle analysis
44. Growth state and cell cycle dependent phosphorylation of DNA topoisomerase II in Swiss 3T3 cells
45. Human topoisomerase II α is phosphorylated in a cell-cycle phase-dependent manner by a proline-directed kinase
46. Complementation of temperature-sensitive topoisomerase II mutations in Saccharomyces cerevisiae by a human TOP2 β construct allows the study of topoisomerase II β inhibitors in yeast
47. LIS1: Cellular function of a disease-causing gene